METHODS AND MATERIALS
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Brachytherapy
- Cancer statistics.CA Cancer J Clin. 2021; 71 (2021): 7-33
Cervical cancer NCCN clinical practice guideline in oncology. Version 1. 2021. Available at: https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed June 14, 2021.
- A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study.Gynecol Oncol. 1999; 73: 177-183
- A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study.Int J Radiat Oncol Biol Phys. 2006; 65: 169-176
- Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.J Clin Oncol. 2000; 18: 1606-1613
- Rethinking the use of radiation and chemotherapy after radical hysterectomy: A clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.Gynecol Oncol. 2005; 96: 721-728
- Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer.Int J Radiat Oncol Biol Phys. 2006; 65: 1501-1507
- The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer.Gynecol Oncol. 2013; 128: 44-48
- Vaginal radiation brachytherapy to reduce central recurrence after radical hysterectomy for cervical carcinoma.Gynecol Oncol. 1990; 38: 187-190
- Postoperative radiotherapy in early stage carcinoma of the uterine cervix: Treatment results and prognostic factors.Gynecol Oncol. 1999; 72: 10-15
- Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: A retrospective clinical study.Radiat Oncol. 2015; 10: 189
- Vaginal cuff brachytherapy in the adjuvant setting for patients with high-risk early-stage cervical cancer.Brachytherapy. 2019; 18: 747-752
- Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).Int J Gynecol Cancer. 2021; 31: 185-193
- Comparison of chemoradiotherapy with and without brachytherapy as adjuvant therapy after radical surgery in early-stage cervical cancer with poor prognostic factors: An observational study.Medicine (Baltimore). 2017; 96: e8384
- Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute.Cancer. 1995; 76: 2343-2350
National Cancer Institute. The Surveillance, Epidemiology, and End Results (SEER) Program. 2021. Available at: http://seer.cancer.gov. Accessed June 14, 2021.
National Cancer Registrars Association. Available at: https://www.ncra-usa.org/. Accessed June 14, 2021.
- Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.Int J Cancer. 2017; 141: 1042-1051
- Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.Am J Obstet Gynecol. 2020; 222 (484 e481-484 e415)
- The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies.J Clin Oncol. 2003; 21: 2232-2233
- Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.Gynecol Oncol. 2015; 136: 48-53
- Gynecologic oncology group surgical procedures manual.Gynecologic Oncology Group, Philadelphia, PA2009
- Outcome modelling strategies in epidemiology: Traditional methods and basic alternatives.Int J Epidemiol. 2016; 45: 565-575
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.Stat Med. 2015; 34: 3661-3679
- Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States.Int J Gynecol Cancer. 2021; 31: 991-1000
- Introduction to the analysis of survival data in the presence of competing risks.Circulation. 2016; 133: 601-609
- A proportional hazards model for the subdistribution of a competing risk.J Am Stat Assoc. 1999; 94: 496-509
- STROBE reporting guidelines for observational studies.JAMA Surg. 2021; 156: 577-578
- Adjuvant external beam radiation and brachytherapy for vaginal resection margin positive cervical cancer.Radiat Oncol J. 2018; 36: 147-152
- Survival benefit of adjuvant brachytherapy after hysterectomy with positive surgical margins in cervical cancer.Int J Radiat Oncol Biol Phys. 2018; 102: 373-382
- Adjuvant radiotherapy for cervical cancer in South Korea: A radiation oncology survey of the Korean Radiation Oncology Group (KROG 20-06).Jpn J Clin Oncol. 2021; 51: 1107-1113
- The addition of brachytherapy to adjuvant external beam radiation improves survival in cervical cancer patients following surgery.Int J Radiat Oncol Biol Phys. 2014; 90: S474-S475
- Addition of brachytherapy to adjuvant external beam radiation in patients with cervical cancer.Brachytherapy. 2016; 15: S113-S114
- The ASTRO clinical practice guidelines in cervical cancer: optimizing radiation therapy for improved outcomes.Gynecol Oncol. 2020; 159: 607-610
- Minimally invasive versus abdominal radical hysterectomy for cervical cancer.N Engl J Med. 2018; 379: 1895-1904
- Evaluation of adjuvant vaginal vault brachytherapy in early stage cervical cancer patients.Cancer Radiother. 2020; 24: 860-865
- Interstitial preoperative high-dose-rate brachytherapy for early stage cervical cancer: dose-volume histogram parameters, pathologic response and early clinical outcome.Brachytherapy. 2013; 12: 148-155
- Effect of a randomized, controlled trial on surgery for cervical cancer.N Engl J Med. 2021; 384: 1669-1671
- Decreasing utilization of minimally invasive hysterectomy for cervical cancer in the United States.Gynecol Oncol. 2021; 162: 43-49
- Association of radical hysterectomy surgical volume and survival for early-stage cervical cancer.Obstet Gynecol. 2019; 133: 1086-1098
Disclosures: Consultant, Quantgene (LDR); honorarium, Chugai, textbook editorial expense, Springer, investigator meeting attendance expense, VBL Therapeutics (KM) (all, outside this work). This work was supported by Ensign Endowment for Gynecologic Cancer Research (KM). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Abstract presentation: 103rd Annual Meeting of American Radium Society, Maui, HI, September 29–October 3, 2021.